Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 30, 2024 08:01 ET | Source: Research and Markets

DSUVIA (sufentanil) Drug Insights and U.S. Market Analysis, 2023-2032

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "United States DSUVIA Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This extensive report...
June 15, 2021 18:15 ET | Source: The Rosen Law Firm PA

ACRX SHAREHOLDER ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ACRX

WHY: NEW YORK, June 15, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of AcelRx...